In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host  Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Roger Lias Chief Executive Officer at Stelis Biopharma Pvt. Ltd. and Stelis Biopharma LLC, Mark Quick, Executive Vice President Corporate Development at Recipharm AB, Lynn Allen, Vice President Of Business Development at MedPharm Ltd, Alfredo Gomez, Head of Site at Idifarma, and Rick Seibert, Sr. Vice President, Innovation and Technology Services at Sharp Clinical Services.
This session will involve a wider discussion around COVID-19 related trends and also natural progression in the CDMO space. We will begin by exploring recurring trends involving futureproofing and digitisation across the industry including a growing need for automation.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.